Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Titan Pharmaceuticals Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
TTNP is no longer listed, so this page shows Q3 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 18
- −2 vs. Q2 2025
- Shares held
- 22.4K
- −15.3K (−40.7%) vs. Q2 2025
- Total value
- $107.1K
- −$51.2K (−32.3%) vs. Q2 2025
- New holders
- 3
- 1 more added
- Sold out
- 5
- 1 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $69 |
| Q1 2026 | 6 | $130 |
| Q4 2025 | 4 | $154 |
| Q3 2025 | 18 | $107.1K |
| Q2 2025 | 20 | $158.3K |
| Q1 2025 | 17 | $51.9K |
| Q4 2024 | 15 | $9.41K |
| Q3 2024 | 16 | $88.5K |
| Q2 2024 | 18 | $179.3K |
| Q1 2024 | 17 | $230.0K |
| Q4 2023 | 24 | $408.2K |
| Q3 2023 | 27 | $497.8K |
| Q2 2023 | 25 | $632.7K |
| Q1 2023 | 22 | $787.4K |
| Q4 2022 | 23 | $757.9K |
| Q3 2022 | 21 | $1.14M |
| Q2 2022 | 24 | $371.0K |
| Q1 2022 | 24 | $1.24M |
| Q4 2021 | 24 | $430.0K |
| Q3 2021 | 22 | $722.0K |
| Q2 2021 | 23 | $1.51M |
| Q1 2021 | 24 | $988.1K |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Titan Pharmaceuticals Inc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DRW Securities, LLC | 21,267 | $101.9K | 0.01% | +21,267 | New |
| UBS Group AG | 480 | $2.30K | 0.00% | −2,947−86.0% | Reduced |
| Tower Research Capital LLC (TRC) | 469 | $2.25K | 0.00% | +469 | New |
| CoreCap Advisors, LLC | 88 | $422 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 19 | $91 | 0.00% | +1+5.6% | Added |
| Group One Trading, L.P. | 12 | $58 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10 | $35 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 6 | $29 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2 | $10 | 0.00% | 00.0% | Unchanged |
| Global Wealth Strategies & Associates | 2 | $10 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 1 | $5 | 0.00% | 00.0% | Unchanged |
| St Germain D J Co Inc | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 1 | $5 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Nemes Rush Group LLC | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Ransom Advisory, Ltd | 1 | $5 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $0 | 0.00% | +1 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,069−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −11,380−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −10,663−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Cape Investment Advisory, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |